CD274 and neoplasm: However, ablation of a subpopulation of stromal cells (FAP+ cells) permitted immune control of tumor growth and uncovered the efficacy of immunotherapeutic antibodies (anti-CTLA-4 or anti-PD-L1), which resulted in acute tumor regression (Kraman et al., 2010; Feig et al., 2013).